#oncology #Mitazalimab #survivalrates #phase2study #survivalbenefit #AlligatorBioscience #phase2clincialtrial #OPTIMIZE1study #combinationtherapy #mFOLFIRINOX #metastaticpancreaticcancer #pancreaticcancer #pancreaticcancerpatients #clinicaltrials #drugdevelopment
pharmatimes.com/news/mitazal...
pharmatimes.com/news/mitazal...
Mitazalimab shows promising survival rates in cancer study - PharmaTimes
Updated data from phase 2 study reveals survival benefit
pharmatimes.com
February 28, 2025 at 9:48 AM